Valeant Pharmaceuticals (VRX). Sequoia, however, had a successful history of loading up on a stock or two, so I wasn’t particularly worried. For many years, it owned a ton of Berkshire Hathaway ...
Bausch Health, formerly known as Valeant Pharmaceuticals, is a multinational specialty pharmaceutical company with global ...
Anupreeta Das joins Paul Vigna, Erik Holm, Stephen Grocer, Maureen Farrell in studio to break down the biggest takeaways from Warren Buffett's annual shareholder letter discussing Berkshire Hathaway's ...
Safkhet Capital's Quadir, known for her short call on Valeant Pharmaceuticals, alleges that she has concerns about the for-profit university in the report. Adtalem (ATGE) said it moved up its Q2 ...
The FDA has finally approved Valeant’s eye drug Vyzulta after the ... its recently approved psoriasis drug. Sun Pharma's Taro unit has made a bid to acquire Canadian biotech Antibe, a developer ...
a first-in-class potassium-channel opener developed by Valeant Pharmaceuticals for the treatment of epilepsy. GSK will also gain the rights to Valeant's back-up compounds that target potassium ...